ArticleFrontiers in pharmacology2020

Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases.

Yu Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.